Keyphrases
Pancreatic Cancer
100%
Neoadjuvant
100%
Effector T Cells
100%
FOLFIRINOX
100%
Suppressor Cells
100%
Pancreatic Ductal Adenocarcinoma
33%
Treg
22%
CD8+ T Cells
22%
Nave
22%
CD39
22%
Tumor
11%
Clinical Outcomes
11%
Resection
11%
Inflammatory Monocytes
11%
Immune Suppression
11%
Cell Population
11%
Peripheral Blood Mononuclear Cells
11%
Monocytes
11%
Th2 Cells
11%
Immune System
11%
Peripheral Blood
11%
Neoadjuvant Therapy
11%
Chemotherapy-induced
11%
CD4 T Cells
11%
Neoadjuvant Chemotherapy
11%
Th1 Cells
11%
Immune Therapy
11%
Antitumor Immune Response
11%
Immunogenic Cell Death
11%
CyTOF
11%
T-bet
11%
Immune Profile
11%
Immune Parameters
11%
Mass Cytometry
11%
Untreated Patients
11%
Therapy Outcome
11%
Effector Memory
11%
Regulatory T Cell(Treg)
11%
Cellular Alterations
11%
CD27
11%
High-dimensional Profiling
11%
Memory Subsets
11%
Immunology and Microbiology
T Cell
100%
Regulatory T Cell
100%
Suppressor Cell
100%
Cytotoxic T-Cell
50%
Immunity
50%
T-Helper Cell
25%
Immunocompetent Cell
25%
Cell Population
25%
Immune Response
25%
Cell Death
25%
Immunotherapy
25%
Th2 Cell
25%
Flight
25%
Th1 Cell
25%
Mass Cytometry
25%
Immune System
25%
Peripheral Blood Mononuclear Cell
25%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Regulatory T Cell
100%
Immunity
100%
CD8
50%
Cell Death
25%
Immune Response
25%
Peripheral Blood Mononuclear Cell
25%
CD4
25%
Immunocompetent Cell
25%
Mass Cytometry
25%
Cytometry by Time of Flight
25%
CD27
25%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Cancer
100%
Pancreas Adenocarcinoma
100%
Chemotherapy
66%
CD8 Antigen
66%
Neoplasm
33%
Immunotherapy
33%
Immunogenic Cell Death
33%